TEM (TEM)

$49.62
-6.02%
$9.1B
Market Cap
P/E Ratio
Beta
Dividend Yield
Piotroski 4/9Altman Z 1.8 DistressBeneish M -1.18 Flag (> −2.22)ROIC−WACC -19.2%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 4/9, Altman Z 1.8. Beneish M-Score of -1.18 exceeds the -2.22 academic threshold — earnings quality may warrant further review.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics of this entity present a stark dichotomy between top-line expansion and bottom-line erosion. While revenue growth surged 83.4% year-over-year, the company operates with a net margin contraction to -19.3%, driving ROIC into negative territory at -9.2%. This profitability weakness is mathematically evident in the DuPont decomposition; despite an equity multiplier of 4.63x indicating significant leverage and gross margins holding steady at 62.7%, asset turnover remains modest at 0.56x, resulting in a severely depressed ROE of -49.9%. Credit risk metrics further highlight operational fragility, with the Piotroski F-Score registering only 4/9, suggesting limited financial strength relative to peers.

Valuation and market pricing appear disconnected from these deteriorating profitability fundamentals. The stock exhibits strong momentum characteristics, evidenced by a substantial annualized Fama-French alpha of 33.23% and a clear growth tilt with an HML factor of -0.843. However, this aggressive price appreciation is occurring alongside severe weakness in the RMW (Robustness of Margins) dimension, which scores -2.179. The market appears to be pricing in future margin recovery or continued revenue scaling that has not yet materialized in earnings per share, creating a potential divergence between current valuation multiples and sustainable cash flow generation given the negative net income environment.

Insider activity introduces additional cautionary signals into the risk-reward profile. Over the past ninety days, insiders have executed net selling totaling $33 million, a significant outflow that often precedes periods of elevated downside volatility or reflects internal skepticism regarding future guidance. When combined with the weak profitability factor and negative ROIC, this insider behavior suggests management may not be fully aligned with current market expectations or optimistic growth narratives. The convergence of high valuation premiums driven by revenue momentum against deteriorating unit economics and significant insider distribution creates a complex setup where short-term alpha generation could face headwinds if margin expansion fails to accelerate rapidly enough to offset the negative returns on invested capital.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

4/9
Piotroski F-Score
Average — mixed operational signals
1.8
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-1.18
Beneish M-Score
Above threshold — earnings quality may warrant further review per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

62.7%
Gross Margin
-19.3%
Net Margin
-9.2%
ROIC
10.0%
WACC
ROIC − WACC Spread: -19.2%— Negative spread.
+83.4%
Revenue Growth (YoY)
+65.3%
Earnings Growth (YoY)
-245.4M
Free Cash Flow

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

-19.3%
Net Profit Margin
NI ÷ Revenue
×
0.56x
Asset Turnover
Revenue ÷ Assets
×
4.63x
Equity Multiplier
Assets ÷ Equity
=
-49.9%
Return on Equity
⚠️ High equity multiplier — ROE is being amplified by leverage, not operational excellence.

Balance Sheet Health

3.63x
Debt / Equity
3.13x
Current Ratio
-3.1x
Interest Coverage
-2.94%
FCF Yield
-118.5M
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
-$33M
Net Selling
0
Buy Transactions
13
Sale Transactions
2026-03-26LEFKOFSKY ERIC PAULSold 6/8 qtrsSale$8M
2026-03-02ROGERS JAMES WILLIAMSold 6/8 qtrsSale$578,576
2026-03-02EPSTEIN DAVID RSold 6/8 qtrsSale$12,672
2026-02-20POLOVIN ANDREWSold 6/8 qtrsSale$1M
2026-02-20POLOVIN ANDREWSold 6/8 qtrsGrant38,420 shares

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✓ Beat
Est: $-0.27
Act: $-0.24
+10.2%
Q3
✓ Beat
Est: $-0.25
Act: $-0.22
+13.0%
Q2
✓ Beat
Est: $-0.18
Act: $-0.11
+37.3%
Q1
✓ Beat
Est: $-0.05
Act: $-0.04
+22.1%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Risk Profile

100.1%
Annual Volatility
0.35
Sharpe (1Y)
-59.3%
Max Drawdown (5Y)

Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fama-French 5-Factor Exposure

Academic factor model decomposition — what's really driving this stock's returns.

1.80
Market β
Mkt-RF
+2.160
Size (SMB)
Small-cap tilt
-0.843
Value (HML)
Growth tilt
-2.179
Profit (RMW)
Weak
+0.316
Invest (CMA)
Conservative
Alpha (annual): +33.23%
R²: 33.3%of variance explained by 5 factors

Fama-French 5-Factor Model. Data: Kenneth French Data Library. Regression over 3 years of daily returns.

Fundamentals

-367.1
Forward P/E
PEG Ratio
18.29
Price/Book
6M
Avg Volume
$104.32
52W High
$41.73
52W Low
13%
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$690M
Tracked Passive Exposure
7
ETFs Holding TEM
0.19%
Avg Weight in ETFs
$366B
Total ETF AUM

When investors buy or sell ETFs like ARKG or ARKK, the fund manager is mechanically forced to buy or sell TEM shares regardless of TEM's individual fundamentals. We estimate $690M of passive capital is structurally linked to TEM through 7 tracked ETFs. Passive flows have a limited but growing influence on TEM's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 7 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in TEM to visualize passive redemption contagion across ETFs and collateral stocks.

TEM Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
TEMEpicenterVBETFVXFETFVONGETFCRSPLow RiskLLYLow RiskTWSTLow RiskTSLALow RiskJNJLow Risk
TEM Price Drop (%)0

If TEM (TEM) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies CRISPR THERAPEUTICS AG (CRSP) as the most exposed collateral stock, sharing 2 ETFs with TEM. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 7 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

TEM Ownership Dynamics

Passive funds hold 1 in every 12 TEM shares, reducing daily market volatility.

Ticker
TEM
Total Shares
175M
ETF Lock-Up
8.2%
Display Mode
Total Float Impact
8.2%Locked Float

TEM (TEM) exerts measurable gravity on the passive index market, currently representing 8.0% of the ARK Genomic Revolution ETF (ARKG) and 4.7% of the ARK Innovation ETF (ARKK). Across 8 tracked ETFs, approximately 14M shares (8.2% of float) are held by passive funds and rarely trade on the open market. As passive ownership grows, index inclusion changes may increasingly drive price discovery.

Float lock-up computed from 8 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

TEM Institutional Volume Profile

252-day volume distribution by price level. The Point of Control (POC) marks the price where the most institutional volume transacted — an implicit support/resistance floor.

TICKER
TEM
PRICE
$49.62
FLOOR (POC)
$59.06
STRENGTH
Medium
$43$47$506%$49.62$537%$567%$59POC 11%$629%$657%$6810%$727%$756%$78$81$84$87$90$93$97$100$103
Focus Zone
Point of Control (POC) Support (below price) Resistance (above price) Current Price

The highest-volume price zone for TEM over the past year sits near $59.06 (11% of 252-day volume). The current price of $49.62 sits 16.0% below the POC — suggesting potential mean-reversion upside if institutional demand reasserts at this level.

Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-14747,761$45.90$34.3M
2026-05-13377,337$46.95$17.7M
2026-05-121,615$48.46$78,262.9
2026-05-08382,652$49.47$18.9M
2026-05-04256$55.00$14,080
2026-04-285,298$52.68$279,098.64
2026-04-2791,210$52.12$4.8M
2026-04-24116,632$51.44$6.0M
2026-04-2335,312$55.51$2.0M
2026-04-2289,616$55.15$4.9M
2026-04-218,469$56.78$480,869.82
2026-04-20145,444$55.87$8.1M
2026-04-16137,937$56.41$7.8M
2026-04-1544,653$49.53$2.2M
2026-04-1455$45.98$2,528.9
2026-04-13100$42.94$4,294
2026-04-1057,998$44.16$2.6M
2026-04-098,712$47.50$413,820
2026-04-06187,798$47.39$8.9M
2026-04-0220,696$47.03$973,332.88
2026-03-3162$42.37$2,626.94
2026-03-3057,559$42.62$2.5M
2026-03-276,754$45.53$307,509.62
2026-03-26102,518$46.76$4.8M
2026-03-252,218$48.83$108,304.94
2026-03-24565$49.14$27,764.1
2026-03-2321,935$46.96$1.0M
2026-03-2054,156$48.74$2.6M
2026-03-1912,439$48.69$605,654.91
2026-03-182,899$50.84$147,385.16

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

SEC Comment Letters

SEC correspondence with the company regarding their filings. Comment letters often flag disclosure deficiencies, accounting concerns, or material omissions.

Source: SEC EDGAR correspondence. Comment letters are public records of SEC staff review of company filings.

Price Correlations

Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.

Peer252-Day (1Y)126-Day (6M)Direction
WTGXXNaNNaN
PSNL0.5440.532Moderate
ACHR0.5020.601Moderate
ROK0.4770.427Moderate
RXRX0.4670.541Moderate
TRMB0.4660.498Moderate
TWST0.4580.489Moderate
HOOD0.4480.555Moderate
EMR0.4480.501Moderate
MTD0.4410.335Moderate

Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.

Compare TEM to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.